Search Results - "SUSUMU, Nobuyuki"
-
1
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia
Published in Reproductive biology and endocrinology (15-01-2016)“…Patients hoping to preserve their fertility receive conservative treatment with high-dose medroxyprogesterone acetate (MPA) for well-differentiated…”
Get full text
Journal Article -
2
Intratumoral CD8+ Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer
Published in International journal of gynecological cancer (01-09-2015)“…Microsatellite instability (MSI) is caused by a defective DNA mismatch repair system. Colorectal cancer in MSI-positive patients is characterized by an…”
Get more information
Journal Article -
3
ADAM9 is over‐expressed in human ovarian clear cell carcinomas and suppresses cisplatin‐induced cell death
Published in Cancer science (01-02-2018)“…ADAMs (a disintegrin and metalloproteinases) are involved in various biological events such as cell adhesion, migration and invasion, membrane protein shedding…”
Get full text
Journal Article -
4
Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer
Published in International journal of gynecological cancer (01-12-2011)“…Host antitumor immune responses are associated with many types of immune cells and soluble components. In particular, CD8 cytotoxic T lymphocytes (CTLs) play a…”
Get more information
Journal Article -
5
Phase II Evaluation of Paclitaxel and Carboplatin in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study
Published in Journal of clinical oncology (01-06-2010)“…Platinum and taxane compounds have demonstrated activity in uterine carcinosarcoma (malignant mixed Mullerian tumor). Ifosfamide plus paclitaxel is the regimen…”
Get full text
Journal Article -
6
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)
Published in Journal of gynecologic oncology (01-11-2024)“…Fertility preserving therapy using medroxyprogesterone acetate (MPA) is an important option for young patients with endometrial cancer or atypical endometrial…”
Get full text
Journal Article -
7
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
Published in Journal of gynecologic oncology (01-03-2018)“…Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical…”
Get full text
Journal Article -
8
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary
Published in International journal of gynecological cancer (01-11-2014)“…Clear cell carcinoma of the ovary (CCC) is a histologic subtype of epithelial ovarian cancer with a distinct clinical behavior. There are marked geographic…”
Get more information
Journal Article -
9
Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study
Published in International journal of clinical oncology (01-05-2021)“…Background Sentinel lymph node (SN) biopsy is essential for evaluating survival and minimal treatment-related morbidity associated with cervical, endometrial,…”
Get full text
Journal Article -
10
MicroRNAs in endometrial cancer
Published in International journal of clinical oncology (01-04-2013)“…MicroRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs) of approximately 22 bp that induce RNA interference with a complementary messenger RNA (mRNA)…”
Get full text
Journal Article -
11
Identification of a novel uterine leiomyoma GWAS locus in a Japanese population
Published in Scientific reports (27-01-2020)“…Uterine leiomyoma is one of the most common gynaecologic benign tumours, but its genetic basis remains largely unknown. Six previous GWAS identified 33 genetic…”
Get full text
Journal Article -
12
Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers
Published in International journal of gynecological cancer (01-03-2015)“…Synchronous primary endometrial and ovarian cancers have been an important topic in clinical medicine because it is sometimes difficult to distinguish whether…”
Get more information
Journal Article -
13
Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group
Published in International journal of clinical oncology (01-02-2016)“…Background Uterine carcinosarcomas (UCSs) are rare and aggressive tumors. The prognostic factors are not sufficiently known. Methods We performed a…”
Get full text
Journal Article -
14
Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors
Published in Cancer medicine (Malden, MA) (01-10-2020)“…Precision medicine based on cancer genomics is being applied in clinical practice. However, patients do not always derive benefits from genomic testing. Here,…”
Get full text
Journal Article -
15
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
Published in Journal of gynecologic oncology (01-11-2022)“…OBJECTIVEThe aim of this study was to establish criteria that would indicate whether fertility preservation therapy would likely be safe for patients aged 40…”
Get full text
Journal Article -
16
Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients
Published in Journal of human genetics (01-12-2013)“…Irinotecan is a key chemotherapeutic drug used to treat many tumors, including cervical and ovarian cancers; however, irinotecan can cause toxicity,…”
Get full text
Journal Article -
17
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma
Published in International journal of gynecological cancer (01-11-2014)“…Uterine serous carcinoma (USC) represents a rare and aggressive histologic subtype of endometrial cancer, associated with a poor prognosis. This article…”
Get more information
Journal Article -
18
Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings
Published in International journal of gynecological cancer (01-10-2011)“…To clarify the preoperative differential diagnosis and management of minimal deviation adenocarcinoma (MDA) and lobular endocervical glandular hyperplasia…”
Get more information
Journal Article -
19
A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial Cancer
Published in International journal of gynecological cancer (01-09-2017)“…Sentinel nodes (SNs) have been observed in several reports from Japan and overseas in cases with endometrial cancer; however, no consensus has been reached…”
Get more information
Journal Article -
20
Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation
Published in The journal of obstetrics and gynaecology research (01-04-2017)“…Aim To examine the usefulness of the neutrophil : lymphocyte (N/L) ratio as a cost‐effective and simple diagnostic marker of mature cystic teratoma (MCT) with…”
Get full text
Journal Article